AU Patent

AU7132998A — Substituted pyrrolopyridines useful in the treatment of inflammatory diseases

Assigned to ORTHO-MCNEIL Corp Inc · Expires 1998-11-13 · 28y expired

What this patent protects

Patent listed against nintedanib-esylate.

Drugs covered by this patent

nintedanib-esylate (NINTEDANIB ESYLATE)

Patent Metadata

Patent number: AU7132998A
Jurisdiction: AU
Classification: —
Expires: 1998-11-13
Drug substance claim: No
Drug product claim: No
Assignee: ORTHO-MCNEIL Corp Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.